BioSpace News Archive

A direct result of using better technology leads to an increase in high quality data gathered.

Most of the jobs are field-based positions across the U.S., although some will be in Thousand Oaks, California at the company’s headquarters.

Companies from across the globe provide updates on their businesses and pipelines.

Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system

The International Center for Materials Nanoarchitectonics, a unit of the National Institute for Materials Science, had a visit from Prof. Allan S. Hoffman from the University of Washington, a pioneer in smart polymers and biomaterials research, for the International Symposium on Smart Biomaterials held in Tsukuba on Sept. 9.

Lysogene, a pioneering Phase 3 biopharmaceutical company specializing in gene therapy targeting central nervous system diseases, reports its cash position as of 30 September 2019.

Japanese Ministry of Health, Labour and Welfare grants orphan drug designation for diseases that affect fewer than 50,000 patients in Japan, and for which significant unmet medical need exists

CQC gets VQE “off the ground” and provides an efficient route towards simulating excited molecules using quantum computers

MMS Holdings announced that its regional operations in South Africa has more than doubled in the past fiscal year, through the addition of new colleagues in Bloemfontein and the successful procurement of key contracts with clinical trial sponsors and research groups.

TISSIUM, a privately-owned life science company developing fully synthetic, biomorphic programmable polymers, announced it has raised €38.75 million in a Series B round of funding.